CTLA4 and melanoma: In mice, early steroid administration was shown to be associated with regrowth of initially responsive tumors.35 Among a small cohort of patients with melanoma receiving CTLA-4 blockade, early steroid administration was associated with decreased OS.35 The absence of steroid administration early in treatment may allow time for a durable antitumor response to develop and persist despite later steroid exposure.